Related Experiment Videos
Diagnosis and treatment of disseminated intravascular coagulation
1Department of Pediatrics, Division of Hematology Oncology, All India Institute of Medical Sciences, New Delhi 110 029, India. sambakh@hotmail.com
Insights
Disseminated intravascular coagulation (DIC) involves complex clotting and bleeding issues. D-dimer is the most sensitive diagnostic test, and treatment focuses on the underlying cause, not just symptoms.
Area of Science:
- Hematology
- Critical Care Medicine
Background:
- Disseminated intravascular coagulation (DIC) is a life-threatening syndrome characterized by widespread activation of coagulation and fibrinolysis.
- It involves consumption of clotting factors and inhibitors, leading to both bleeding and thrombosis.
- Traditional diagnostic markers may be unreliable in chronic DIC cases.
Purpose of the Study:
- To review controversies in the diagnosis and management of DIC.
- To highlight the diagnostic utility of D-dimer.
- To discuss therapeutic strategies, including the role of anticoagulants.
Main Methods:
- Literature review of existing studies and clinical guidelines on DIC.
- Analysis of diagnostic criteria and therapeutic interventions.
- Discussion of controversial aspects in DIC management.
Main Results:
- Bleeding is a common manifestation, but microvascular thrombosis causes significant morbidity and mortality.
- D-dimer estimation is the most sensitive and specific diagnostic marker for DIC.
- Standard tests like platelet count and prothrombin time can be normal in chronic DIC.
Conclusions:
- Effective DIC management requires addressing the primary underlying condition.
- Transfusion products (FFP, platelets) carry risks and are reserved for bleeding patients.
- The roles of heparin and antithrombin in sepsis-associated DIC warrant careful consideration.
Abstract:
Disseminated intravascular coagulation (DIC) is a complex clinical syndrome with activation of the procoagulant and fibrinolytic systems along with inhibitor consumption. We discuss regarding the controversies in diagnosis and management of DIC. Bleeding is a more common manifestation of DIC but most of the morbidity and mortality of DIC is due to microvascular thrombosis. Routinely performed tests for DIC such as platelet count and prothrombin time may be normal in chronic DIC. There is no single test that would diagnose DIC, however, estimation of D-dimer appears to be the most sensitive and specific test. Therapy of DIC aims at treating the primary cause. Fresh frozen plasma and platelet concentrates are recommended only in bleeding patients and have the potential risk of adding procoagulant material to the already activated procoagulant system. Role of heparin and antithrombin in patients with sepsis and DIC is discussed.